Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery
Source abstract
Abstract
Lipid-based nanoparticles (LNPs) for the delivery of mRNA have jumped to the forefront of non-viral gene delivery. Despite this exciting development, poor endosomal escape after LNP cell entry remains an unsolved, rate-limiting bottleneck. Here we report the use of a galectin 8-GFP (Gal8-GFP) cell reporter system to visualize the endosomal escape capabilities of LNP-encapsulated mRNA. LNPs substituted with phytosterols in place of cholesterol exhibited various levels of Gal8 recruitment in the Gal8-GFP reporter system. In live-cell imaging, LNPs containing β-sitosterol (LNP-Sito) showed a 10-fold increase in detectable endosomal perturbation events when compared to the standard cholesterol LNPs (LNP-Chol), suggesting the superior capability of LNP-Sito to escape from endosomal entrapment. Trafficking studies of these LNPs showed strong localization with late endosomes. This highly sensitive and robust Gal8-GFP reporter system can be a valuable tool to elucidate intricacies of LNP trafficking and ephemeral endosomal escape events, enabling advancements in gene delivery.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · RNA regulation and disease · Galectins and Cancer Biology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Sciences
College of Pharmacy
Robertson Life Sciences Building
Oregon State University
Portland
Funding
National Heart, Lung, and Blood Institute · National Eye Institute · Cystic Fibrosis Foundation · National Institutes of Health · Oregon Health and Science University
References (48)
Show source-provided references
1. Sahin · Nat. Rev. Drug Discovery · 2014 · 13 · 75910.1038/nrd4278 ↗
2. Kaczmarek · Genome Med. · 2017 · 9 · 6010.1186/s13073-017-0450-0 ↗
3. Pack · Nat. Rev. Drug Discovery · 2005 · 4 · 58110.1038/nrd1775 ↗
4. Dowdy · Nat. Biotechnol. · 2017 · 35 · 22210.1038/nbt.3802 ↗
5. Yin · Nat. Rev. Genet. · 2014 · 15 · 54110.1038/nrg3763 ↗
6. Adams · N. Engl. J. Med. · 2018 · 379 · 1110.1056/NEJMoa1716153 ↗
7. Balwani · N. Engl. J. Med. · 2020 · 382 · 228910.1056/NEJMoa1913147 ↗
8. He · Acc. Chem. Res. · 2019 · 52 · 244510.1021/acs.accounts.9b00228 ↗
9. Walsh · N. Engl. J. Med. · 2020 · 383 · 243910.1056/NEJMoa2027906 ↗
10. Corbett · N. Engl. J. Med. · 2020 · 383 · 154410.1056/NEJMoa2024671 ↗
11. Patel · Adv. Drug Delivery Rev. · 2019 · 144 · 9010.1016/j.addr.2019.08.004 ↗
12. Sahay · Nat. Biotechnol. · 2013 · 31 · 65310.1038/nbt.2614 ↗
13. Kim · Theranostics · 2019 · 9 · 319110.7150/thno.33921 ↗
14. Gilleron · Nat. Biotechnol. · 2013 · 31 · 63810.1038/nbt.2612 ↗
15. Ballabio · EMBO Mol. Med. · 2016 · 8 · 7310.15252/emmm.201505966 ↗
16. Nakamura · J. Cell Sci. · 2017 · 130 · 120910.1242/jcs.196352 ↗
17. Wittrup · Nat. Biotechnol. · 2015 · 33 · 87010.1038/nbt.3298 ↗
18. Vermeulen · ACS Nano · 2018 · 12 · 233210.1021/acsnano.7b07583 ↗
19. Arthur · Methods Mol. Biol. · 2015 · 1207 · 110.1007/978-1-4939-1396-1_1 ↗
20. Rabinovich · Nat. Rev. Immunol. · 2009 · 9 · 33810.1038/nri2536 ↗
21. Stowell · Nat. Med. · 2010 · 16 · 29510.1038/nm.2103 ↗
22. Tsai · J. Immunol. · 2011 · 187 · 164310.4049/jimmunol.1100297 ↗
23. Thurston · Nature · 2012 · 482 · 41410.1038/nature10744 ↗
24. Johannes · J. Cell Sci. · 2018 · 131 · jcs20888410.1242/jcs.208884 ↗
25. Du Rietz · Nat. Commun. · 2020 · 11 · 180910.1038/s41467-020-15300-1 ↗
26. Kilchrist · ACS Nano · 2019 · 13 · 1136
27. Rui · Sci. Adv. · 2019 · 5 · eaay325510.1126/sciadv.aay3255 ↗
28. Patel · Nat. Commun. · 2020 · 11 · 98310.1038/s41467-020-14527-2 ↗
29. Kim · Cell. Mol. Bioeng. · 2020 · 1
30. Sato · Biochim. Biophys. Acta, Lipids Lipid Metab. · 1995 · 1257 · 3810.1016/0005-2760(95)00053-F ↗
31. Field · J. Lipid Res. · 1997 · 38 · 34810.1016/S0022-2275(20)37447-2 ↗
32. Brauner · J. Nutr. · 2012 · 142 · 98110.3945/jn.111.157198 ↗
33. Eygeris · Nano Lett. · 2020 · 20 · 454310.1021/acs.nanolett.0c01386 ↗
34. Patel · Nano Lett. · 2017 · 17 · 571110.1021/acs.nanolett.7b02664 ↗
35. Kim · bioRxiv · 202010.1101/2020.07.24.205583 ↗
36. Jayaraman · Angew. Chem., Int. Ed. · 2012 · 51 · 852910.1002/anie.201203263 ↗
37. Sabnis · Mol. Ther. · 2018 · 26 · 150910.1016/j.ymthe.2018.03.010 ↗
38. Hassett · Mol. Ther.–Nucleic Acids · 2019 · 15 · 110.1016/j.omtn.2019.01.013 ↗
39. Dong · Proc. Natl. Acad. Sci. U. S. A. · 2014 · 111 · 395510.1073/pnas.1322937111 ↗
40. Cheng · Nat. Nanotechnol. · 2020 · 15 · 31310.1038/s41565-020-0669-6 ↗
41. Kulkarni · Acc. Chem. Res. · 2019 · 52 · 243510.1021/acs.accounts.9b00368 ↗
42. Paunovska · ACS Nano · 2018 · 12 · 834110.1021/acsnano.8b03640 ↗
43. Payne · Traffic Cph. Den. · 2007 · 8 · 38910.1111/j.1600-0854.2007.00540.x ↗
44. Bänfer · Biomolecules · 2020 · 10 · 123210.3390/biom10091232 ↗
45. Chen · J. Biol. Chem. · 2014 · 289 · 1116210.1074/jbc.M113.531855 ↗
46. Hong · Glycobiology · 2019 · 30 · 49
47. Mansilla Pareja · Front. Cell. Infect. Microbiol. · 2017 · 7 · 11210.3389/fcimb.2017.00112 ↗
48. Jia · Mol. Cell. · 2018 · 70 · 12010.1016/j.molcel.2018.03.009 ↗